Fullife

Mumbai, India Founded: 2009 • Age: 17 yrs Minicorn
Effervescent nutritional and pharmaceutical products are manufactured by the company.

About Fullife

Fullife is a Healthcare company based in Mumbai (India) founded in 2009 by Varun Khanna. Effervescent nutritional and pharmaceutical products are manufactured by the company. Fullife has raised $84.07 million across 13 funding rounds from investors including Kotak Mahindra Bank, Morgan Stanley and Sixth Sense Ventures. The company has 105 employees. Fullife has completed 1 acquisition, including Novelty Pharma. Fullife was last valued at $76.94 million in February 2022. Its chief executive, as recorded, is Snehal Champaklal. Its Indian entity Fullife Healthcare Private Limited reported revenue of β‚Ή102 Cr. Fullife offers products and services including Fast&Up and Chicnutrix. Its focus areas include Life Sciences, Nutraceuticals Tech, Supplements and Multicategory.

Company details

Fullife was founded in 2009 and is based in Mumbai, India. Operations focus on the manufacture of effervescent products in the nutritional and pharmaceutical sectors. Proprietary HET technology is utilized to develop items such as sports nutrition supplements, womens wellness tablets, and recovery aids for post-party hangover relief. Strategic and exclusive in-licensing agreements are maintained for novel healthcare formulations.

  • Headquarters Mumbai, India
  • Employees 105
  • Founders Varun Khanna
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website fullife.co.in
  • Social LinkedIn
  • Legal Name Fullife Healthcare Private Limited
  • Date of Incorporation 28 Jan, 2010
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹102 Cr

    FY 2025 · +35% YoY

  • Net Loss
    -₹13.42 Cr

    FY 2025 · -5% margin

  • EBITDA
    -₹7.08 Cr

    FY 2025 · -3% margin

  • Total Equity Funding
    $84.07M (USD)

    in 13 rounds

  • Latest Funding Round
    $32M (USD), Series D

    Mar 2026

  • Investors
  • Employee Count
    105
  • Investments & Acquisitions

Products & Services of Fullife

Fullife offers a comprehensive portfolio of products and services, including Fast&Up and Chicnutrix.

Fast&Up
Sports Nutrition

Effervescent supplements for athletes' performance and recovery needs

Chicnutrix
Women's Health

Nutritional products for women's beauty and wellbeing support

Funding Insights of Fullife

Fullife has successfully raised a total of $84.07M across 13 strategic funding rounds. The most recent funding activity was a Series D round of $32 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $84.07M
  • Total Rounds 13
  • Last Round Series D β€” $32M
  • First Round $2.49M

    (Dec 2012)

  • Investors Count 79

Latest 10 of 13 funding rounds of Fullife with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2026$32MSeries D–Elev8
–
Mar 2025$3.29MSeries C––
Feb 2022$1.81MAngel Round$76.94MMayank Agarwal, Shilpa Shetty Kundra
Dec 2021$22MSeries C$76.25MMorgan Stanley, NHPEA Eagle Holding
Jul 2021$4.65MSeries B$β€’β€’β€’β€’β€’Giorgio Baratelli, Goodfightentertainment
Dec 2019$8.65MSeries B$β€’β€’β€’β€’β€’Rakesh Jhunjhunwala
May 2018$4.11MSeries A$β€’β€’β€’β€’β€’Sixth Sense Ventures
May 2018$2.24MSeries A–Sixth Sense Ventures
–
Feb 2017$1.69MSeed$β€’β€’β€’β€’β€’Rakesh Jhunjhunwala
Jul 2015$28,052Angel Round$β€’β€’β€’β€’β€’Vinay Ramakant Sapte
Valuation history
DateValuationStage
Feb 2022$76.94Mβ€’β€’β€’β€’β€’β€’β€’β€’
Dec 2021$76.25Mβ€’β€’β€’β€’β€’β€’β€’β€’
Jul 2021$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Dec 2019$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
May 2018$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Feb 2017$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Jul 2015$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Dec 2012$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Premium access

Full valuation and stage history of Fullife

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $76.94M (Feb 2022). 79 investors in total: 14 institutional and 65 angel.

Investors in Fullife

Fullife has secured backing from 79 investors, including angel, institutional, and venture fund investors. Prominent investors backing the company include Kotak Mahindra Bank, Morgan Stanley and Sixth Sense Ventures.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Venture capital fund investing in consumer-focused startups in India.
2016sixthsenseventures.comMumbai, India
Venture capital firm focused on early-stage investments
Mumbai, India
Private equity firm focused on multiple sectors
Andheri, India
elev8vp.com
Wealth management, investment advisory, and financial services are provided.
1935morganstanley.comNew York, United States
Limited information is available for NHPEA Eagle Holding in Amsterdam.
Amsterdam, Netherlands
Business management consulting services are provided to pharmaceutical firms.
2004pharmaserv.inMumbai, India
goodfightentertainment.com
Provider of investment advisory services
Mumbai, India
Premium access

Investor details for Fullife

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Fullife Healthcare Private Limited (Fullife)

Fullife Healthcare Private Limited is the primary company behind Fullife. The board of Fullife Healthcare Private Limited currently have 8 directors; the longest-serving is Varun Khanna, appointed in 2010. 10 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Varun Khanna
DIN 02293982
Director28 Jan 201016 yrs 9 moFullife Healthcare Private Limited
Snehal Shah Champaklal
DIN 00174521
Director28 Jan 201016 yrs 9 moFullife Healthcare Private Limited
Satish Khanna
DIN 01827559
Director15 Jul 201115 yrs 4 moFullife Healthcare Private Limited
Shilpa Khanna Thakkar
DIN 02839447
Director15 Sep 20179 yrs 2 moFullife Healthcare Private Limited
Rajiv Ambrish Agarwal
DIN 00379990
Director14 Feb 20206 yrs 9 moFullife Healthcare Private Limited
Nirav Vinod Mehta
DIN 07504945
Director07 Dec 20214 yrs 11 moFullife Healthcare Private Limited
Shashank Sinha
DIN 02544431
Director01 Jan 20233 yrs 10 moFullife Healthcare Private Limited
Swati Punitraj Mehra
DIN 06945366
Nominee Director27 Mar 20251 yr 7 moFullife Healthcare Private Limited

People of Fullife

4 people are tracked at Fullife (4 in leadership); the tracked headcount is 105.

NameRoleGroup
Co-FounderLeadership
CEOLeadership
CFOLeadership
CEOLeadership
Premium access

Complete people profiles for Fullife

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Fullife

Figures of Fullife Healthcare Private Limited, the primary company behind Fullife, for FY 2025. Revenue was ₹102 Cr (+35% year on year). Net loss was -₹13.42 Cr (-5% margin). EBITDA was -₹7.08 Cr (-3% margin). Revenue has grown at a compounded annual rate of +21% over three years and +27% over five years.

  • ₹102 CrRevenue · FY 2025 · +35% YoY
  • -₹13.42 CrNet loss · -5% margin
  • -₹7.08 CrEBITDA · -3% margin
  • ₹9.45 CrPaid-up capital
  • 105Employees (provident fund records)
  • +21%Revenue CAGR, 3 years
  • +27%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Fullife Healthcare Private Limited are on its company page.

Premium access

Detailed financial statements for Fullife

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Fullife

Fullife has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Novelty Pharma.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Pharmaceutical formulations are manufactured as a CDMO by Novelty Pharma.
noveltypharma.comCadempino, Switzerland2001Oct 2017β€’β€’β€’β€’
Premium access

Complete acquisition details for Fullife

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Fullife

5 dated milestones of Fullife across 17 years, from founding to its latest funding, stage changes and deals.

  1. Founded Fullife is founded.
  2. Funding First funding round of $2.5M.
  3. Milestone Reaches Minicorn status.
  4. Acquisition Acquires Novelty Pharma.
  5. Funding Latest funding round, Series D, of $32.0M.

Web traffic of Fullife

The website of Fullife (fullife.co.in) receives about 1.4K visits a month.

  • Monthly visits
    1.4K

    ▼ 45.9% vs previous month

Top companies in Nutraceutical & Food-as-Medicine Platforms

3 companies that operate in the same segment as Fullife (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Ayurvedic healthcare and nutritional products are provided by Kapiva.
2016Bengaluru, Karnataka, IndiaUSD 77.85 MUSD 55.41 M362
Nutritional supplements for multiple health ailments are developed.
2005Mumbai, Maharashtra, IndiaUSD 1.55 M
Nutritional food and health supplements are provided by OZiva.
2010Mumbai, Maharashtra, IndiaUSD 17.32 MUSD 56.21 M144
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Fullife

Premium access

Complete news archive for Fullife

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fullife

Fullife was founded in 2009 and raised its 1st funding round 3 years after it was founded.

Fullife is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Snehal Champaklal is the CEO of Fullife, as recorded in our data.

Fullife is a funded company, having raised a total of $84.07M across 13 funding rounds to date. The company's 1st funding round was a Angel Round of $28.05K, raised on Dec 2012.

Fullife has 105 employees.

The primary company behind Fullife, Fullife Healthcare Private Limited, reported revenue of β‚Ή102 Cr for FY 2025, up 35% year on year.

Fullife was founded in 2009 and is based in Mumbai, India. Operations focus on the manufacture of effervescent products in the nutritional and pharmaceutical sectors. Proprietary HET technology is utilized to develop items such as sports nutrition supplements, womens wellness tablets, and recovery aids for post-party hangover relief. Strategic and exclusive in-licensing agreements are maintained for novel healthcare formulations.

Fullife offers Fast&Up and Chicnutrix.

Fullife has made 1 acquisition, including Novelty Pharma.

Fullife has 79 investors. Key investors include Kotak Mahindra Bank, Morgan Stanley, Sixth Sense Ventures, PharmaServ, and Mayank Agarwal.

The valuation of Fullife is $76.94M as of Feb 2022.

Fullife operates through Fullife Healthcare Private Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available